Ducommun Incorporated

NYSE:DCO Rapport sur les actions

Capitalisation boursière : US$2.7b

Ducommun Bilan de santé

Santé financière contrôle des critères 5/6

Ducommun possède un total de capitaux propres de $669.8M et une dette totale de $302.6M, ce qui porte son ratio d'endettement à 45.2%. Son actif total et son passif total sont $1.2B et de $515.5M. L'EBIT de Ducommun est $84.1M ce qui fait que son ratio de couverture des intérêts 6.3. Elle dispose de liquidités et de placements à court terme de $42.0M.

Informations clés

45.18%

Ratio d'endettement

US$302.61m

Dette

Ratio de couverture des intérêts6.3x
Argent liquideUS$41.98m
Fonds propresUS$669.80m
Total du passifUS$515.54m
Total des actifsUS$1.19b

Mises à jour récentes de la santé financière

Pas de mise à jour

Recent updates

Mise à jour du récit Jul 23

DCO: Missile Demand And Aero Recovery Will Offset Defense Budget Concerns

Analysts have lifted their fair value estimate for Ducommun stock from $173.80 to $181.00, reflecting updated views that incorporate recent price target increases across the Street, along with expectations for continued benefits from commercial aerospace strength and missile and munitions demand, tempered by potential budget pressure on parts of the legacy defense portfolio. Analyst Commentary Recent research on Ducommun points to a split view, with bullish analysts highlighting earnings execution and exposure to commercial aerospace and missiles, while more cautious analysts focus on valuation and defense budget risk.
Seeking Alpha Jul 14

Ducommun Incorporated: Real Defense Tailwinds, Few Good Reasons To Wait

Summary Ducommun Incorporated is shifting revenue toward defense, now comprising 58% of FY25 revenues, driving recent stock rerating. I rate DCO a Hold, citing limited current upside, ongoing litigation overhang, and a need for a more defense-centric revenue mix. Valuation remains below peers like Hexcel, but further upside depends on a stronger defense shift and litigation resolution. Existing holders may continue to hold, but new buyers should wait for a better entry price and clearer catalysts. Read the full article on Seeking Alpha
Mise à jour du récit Jul 09

DCO: Missile Demand And Aero Recovery Will Balance Defense Budget And Execution Risks

For Ducommun, the analyst fair value estimate has been revised to $173.80 from $164.00. Analysts point to updated price targets, expectations around missiles and munitions demand, and recent earnings and sector research as the key drivers of this change.
Nouveau récit Jul 02

Missile Demand And Engineered Content Shifts Will Expose Overvaluation Risks

Catalysts About Ducommun Ducommun supplies engineered components and assemblies for commercial aerospace, defense and related industrial applications. What are the underlying business or industry changes driving this perspective?
Mise à jour du récit Jun 25

DCO: Q1 Execution And Aero Recovery Will Balance Restatement Governance Risks

Analysts have lifted their blended price target on Ducommun to approximately $164, reflecting updated models following the company’s Q1 earnings beat and improving commercial aerospace trends, alongside ongoing destocking concerns. Analyst Commentary on Ducommun Recent research on Ducommun points to a generally constructive tone, with price targets raised across multiple firms following the Q1 report and sector model updates, while still flagging a few key risks around end market trends and inventory normalization.
Mise à jour du récit Jun 11

DCO: Q1 Execution And Defense Outlook Will Offset Restatement Governance Risks

Narrative Update on Ducommun Analysts have collectively raised their price targets on Ducommun into a range of about $150 to $187, citing Q1 earnings outperformance, better than expected commercial aerospace demand despite ongoing destocking, and updated aerospace and defense sector models that still indicate potential upside following recent selloffs. Analyst Commentary Recent research updates reflect a generally constructive stance on Ducommun, with higher price targets supported by Q1 execution and expectations around aerospace and defense demand, while still flagging some execution and end market risks.
Mise à jour du récit May 28

DCO: Vision 2032 And Defense Backlog Will Offset Aerospace Destocking Risks

Analysts have lifted the Ducommun fair value estimate from $146.60 to $164.00, reflecting higher sector price targets after Q1 earnings beats and updated assumptions around revenue growth, profit margins, and future P/E multiples. Analyst Commentary Recent Street research on Ducommun highlights a broadly constructive tone after the latest Q1 earnings and earlier Q4 results, with several firms revisiting their models and price targets.
Mise à jour du récit Apr 29

DCO: Defense Backlog And Vision 2032 Framework Will Steady Fair Outlook

Ducommun's updated fair value estimate has moved from $143.20 to $146.60 as analysts factor in a series of higher price targets tied to defense exposure, missile program visibility, and recent margin and backlog trends. Analyst Commentary Recent Street research on Ducommun centers on defense exposure, missile program visibility, and margin execution, which together are feeding into higher fair value estimates and revised price targets.
Mise à jour du récit Apr 10

DCO: Defense Exposure And Vision 2032 Plan Will Shape Balanced Outlook

Analysts have made a slight trim to the Ducommun price target, lowering it by about $0.40. They are balancing recent target hikes tied to defense exposure, missile demand and margin plans with a modest reset following the latest Citi update.
Mise à jour du récit Mar 27

DCO: Defense Exposure And Vision 2032 Plan Will Drive Long Term Upside

Analysts have nudged the Ducommun fair value estimate higher from $142.00 to $143.60. This reflects recent price target increases that are tied to expectations around defense exposure, missile related demand and updated margin ambitions discussed in recent research.
Mise à jour du récit Mar 12

DCO: Defense Momentum And Vision 2032 Plan Will Shape Upside Through 2026

Narrative Update on Ducommun The analyst price target embedded in our fair value framework for Ducommun has been raised from $130 to $142. This change reflects analysts' higher published targets in the $136 to $155 range, supported by recent commentary around margin expansion, record Q4 revenue and EBITDA, defense program visibility, and the Vision 2032 plan focused on proprietary products and free cash flow.
Mise à jour du récit Feb 26

DCO: Defense Agreements And Sector Momentum Will Shape Risk Balance Through 2026

The fair value estimate for Ducommun has been raised from $121.60 to $130.00 as analysts factor in higher Street price targets and improved visibility tied to long term defense agreements and updated aerospace and defense group estimates. Analyst Commentary Recent Street research on Ducommun focuses on higher price targets and updated expectations tied to the defense portfolio and broader aerospace and defense coverage.
Mise à jour du récit Feb 11

DCO: Sector Momentum And Refined Assumptions Will Shape Risk Balance Through 2026

Narrative update on Ducommun The analyst price target for Ducommun has been lifted by $3.80 to $121.60. Analysts point to recent sector wide target increases from firms covering aerospace and defense as support for the higher fair value, as well as a slightly adjusted discount rate and future P/E assumptions.
Mise à jour du récit Jan 28

DCO: Sector Momentum And M&A Plans Will Shape Risk Balance Through 2026

Analysts have increased their Ducommun fair value estimate from US$111.40 to US$117.80. This reflects updated assumptions on the discount rate, revenue growth, profit margins, and a higher future P/E multiple in the context of recent sector-wide price target increases.
Mise à jour du récit Jan 13

DCO: Sector Momentum And Accounting Concerns Will Shape Risk Balance Through 2026

Analysts have lifted their price target on Ducommun to about US$111 from roughly US$106, reflecting updated assumptions on revenue growth, profit margins and a lower expected future P/E, alongside recent sector research indicating momentum in aerospace and defense through the first half of 2026. Analyst Commentary Bullish Takeaways Bullish analysts see the higher US$125 price target as reflecting confidence that Ducommun can support a richer valuation while still using a lower future P/E, given their updated revenue and margin assumptions.
Mise à jour du récit Aug 08

Defense Modernization And Aerospace Recovery Will Reshape Markets

Ducommun's upward price target revision reflects notable improvements in both net profit margin and revenue growth forecasts, resulting in an increased consensus fair value from $99.25 to $106.25. What's in the News Ducommun dropped from the Russell 2000 Dynamic Index.
Seeking Alpha Apr 22

Duocommun: A Good Candidate For A Multi-Year Compounder

Summary Ducommun (DCO) is a promising investment in the aerospace and defense sector, with strong revenue growth potential despite economic challenges. The company’s diverse product offerings and strong financial position support organic growth and acquisitions, with significant contributions from military, space, and commercial aerospace. DCO's backlog and notable contracts with major players like RTX, Boeing, and Airbus indicate robust future revenue and earnings growth. The recent share price drop presents a compelling entry point, with a near-term price target of $75.50 and long-term growth potential. Read the full article on Seeking Alpha
Seeking Alpha Nov 22

Ducommun: Revenue Growth, Airbus Strength, And Vision 2027 Progress

Summary Ducommun reported 2.6% revenue growth, driven by military, space, and Airbus programs. Margins improved, with adjusted EBITDA margin expanding to 15.8% and adjusted EPS up 41%. Robust performance in Airbus A220 and A320 programs offset challenges from Boeing’s strike. Boeing’s recovery is expected to support growth in 2025-2026, especially for the 737 MAX and 787. Facility consolidations and operational streamlining are delivering initial savings, with projected annual savings of $11-13M. Defense backlog increased to $592M, driven by demand for TOW missiles and surveillance. Margin improvements align with DCO’s Vision 2027 goal of 18% adjusted EBITDA margin, supported by strong end markets, cost reductions, and improving aerospace production outlook. Read the full article on Seeking Alpha
Seeking Alpha Sep 19

Ducommun: Aerospace Growth And Strategic Restructuring Amid Boeing Challenges

Summary Ducommun continues to report revenue growth for 2Q24, driven by both commercial aerospace and military end markets. Additionally, margins expanded, driven by engineered products, pricing actions, and restructuring efforts. Despite ongoing challenges with Boeing and Spirit AeroSystems related to the 737 MAX, it achieved 12 consecutive quarters of revenue growth in commercial aerospace. Additionally, DCO's fuselage skin project for the 737 MAX, expected to start production by late 2024, is expected to bolster the company's aerospace business outlook. While the Boeing strike presents near-term headwinds, DCO's strategic restructuring and cost-saving initiatives, combined with improving production rates, are expected to boost margins and profitability in the long term. Read the full article on Seeking Alpha
User avatar
Nouveau récit Sep 16

Strategic Moves And Aerospace Focus Set To Skyrocket Efficiency And Earnings

Consolidating facilities and increasing engineered products and aftermarket content are key strategies to boost operational efficiency and net margins.
Seeking Alpha Jul 16

Ducommun: Robust Air Travel Demand And Defence Backlog

Summary DCO's historical financial results have shown consistent top-line growth. However, margins were contracting modestly. For 1Q24, net revenue continued to grow. Additionally, its margins expanded when compared to previous period. DCO's defence backlog is growing, which is a sign that its defence business is growing. Additionally, DCO raised the run rate of the SPY-6 and other defence programmes. Currently, air travel demand is strong, and ICAO forecasts it to continue growing. The robust air travel demand is expected to bolster the DCO outlook. Read the full article on Seeking Alpha
Seeking Alpha Apr 21

Ducommun: Management Expects Margin Expansion And Revenue Growth

Summary Although Ducommun's commercial aerospace business faced substantial headwinds given the beginning of the pandemic, demand from the market has continued to recover in recent years. On April 16, 2024, Ducommun's board rejected an unsolicited, non-binding indication of interest from Albion River LLC offering $60 in cash per share. Ducommun's board feels the offer doesn't fully reflect the company's Vision 2027 plan where the company sees meaningful adjusted EBITDA margin expansion and continued revenue growth. I rate Ducommun a 'Buy' and I would own it in a diversified portfolio given the company's growth potential and relatively attractive valuation with forward EV/EBITDA ratio of 9.18. Read the full article on Seeking Alpha
Article d’analyse Apr 17

We Think Shareholders May Want To Consider A Review Of Ducommun Incorporated's (NYSE:DCO) CEO Compensation Package

Key Insights Ducommun to hold its Annual General Meeting on 24th of April Salary of US$959.7k is part of CEO Steve...
Article d’analyse Feb 18

Ducommun Incorporated Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Shareholders might have noticed that Ducommun Incorporated ( NYSE:DCO ) filed its annual result this time last week...
Seeking Alpha Feb 06

Ducommun Stock Is Still A Buy On End Market Growth

Summary Ducommun Incorporated has gained 12.9% since September 2023, outperforming the S&P 500. The company operates in the aerospace industry, serving major companies such as Boeing and Airbus. Ducommun has significant growth drivers, including exposure to commercial airplane programs and increased defense budgets. Read the full article on Seeking Alpha
Seeking Alpha Sep 14

Ducommun Aims For A Bigger Piece Of A Growth Pie

Summary Ducommun Incorporated provides engineering and manufacturing services for various industries, including aerospace and defense. Ducommun aims to achieve significant revenue growth and increase its EBITDA through restructuring, cost-cutting measures and accretive acquisitions. The company aims to expand its portfolio and extract more value from that portfolio. Read the full article on Seeking Alpha
Article d’analyse Aug 04

What Does Ducommun Incorporated's (NYSE:DCO) Share Price Indicate?

While Ducommun Incorporated ( NYSE:DCO ) might not be the most widely known stock at the moment, it received a lot of...
Seeking Alpha Jun 19

Ducommun Is Prepared To Face Current And Potential Headwinds

Summary Ducommun's sales have recovered strongly in 2022 and are expected to continue increasing in 2023 and 2024. Margins remain stable despite ongoing headwinds and are expected to improve as the company is moving production capacity to a lower-cost location. The company's debt is highly manageable as it will sell two facilities and land, and annual savings derived from the restructuring process should more than offset increased interest expenses. This represents a good opportunity for long-term patient investors. Read the full article on Seeking Alpha

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de DCO ( $633.9M ) dépassent ses passifs à court terme ( $172.6M ).

Passif à long terme: Les actifs à court terme de DCO ( $633.9M ) dépassent ses passifs à long terme ( $343.0M ).


Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de DCO ( 38.9% ) est considéré comme satisfaisant.

Réduire la dette: Le ratio d'endettement de DCO a été réduit de 92.7% à 45.2% au cours des 5 dernières années.

Couverture de la dette: Le flux de trésorerie opérationnel de DCO est négatif, par conséquent la dette n'est pas bien couverte.

Couverture des intérêts: Les paiements d'intérêts de DCO sur sa dette sont bien couverts par l'EBIT ( 6.3 x couverture).


Bilan


Découvrir des entreprises saines

Analyse de l'entreprise et données financières

DonnéesDernière mise à jour (heure UTC)
Analyse de l'entreprise2026/07/29 10:04
Cours de l'action en fin de journée2026/07/29 00:00
Les revenus2026/04/04
Revenus annuels2025/12/31

Sources de données

Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.

PaquetDonnéesCadre temporelExemple de source américaine *
Finances de l'entreprise10 ans
  • Compte de résultat
  • Tableau des flux de trésorerie
  • Bilan
Estimations consensuelles des analystes+3 ans
  • Prévisions financières
  • Objectifs de prix des analystes
Prix du marché30 ans
  • Cours des actions
  • Dividendes, scissions et actions
Propriété10 ans
  • Actionnaires principaux
  • Délits d'initiés
Gestion10 ans
  • L'équipe dirigeante
  • Conseil d'administration
Principaux développements10 ans
  • Annonces de l'entreprise

* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.

Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.

Modèle d'analyse et flocon de neige

Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github ; nous proposons également des guides sur la façon d’utiliser nos rapports et des tutoriels sur YouTube.

Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.

Indicateurs de l'industrie et du secteur

Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.

Sources des analystes

Ducommun Incorporated est couverte par 12 analystes. 5 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.

AnalysteInstitution
Michael CrawfordB. Riley Securities, Inc.
Kenneth HerbertCanaccord Genuity
John GodynCitigroup Inc